Viewing data from:

RENORMAX

NDA

SPIRAPRIL HYDROCHLORIDE | N020240 | SCHERING CORP

4 strengths0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Products (4)

Sort:

#001 — 3MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 29, 1994

No patent or exclusivity listings for this strength.

#002 — 6MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 29, 1994

#003 — 12MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 29, 1994

#004 — 24MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 29, 1994